Background and objectives: An ideal and effective screening tool should perform equally across ethnic groups. The objective of this study was to determine whether the widely advocated creatinine-based estimated GFR (eGFR) threshold of 60 ml/min per 1.73 m 2 identifies the typical metabolic abnormalities related to chronic kidney disease equally well in minority and nonminority adults.
C reatinine-based estimates of GFR (eGFR) are widely used to define chronic kidney disease (CKD), because they are believed to offer the combination of acceptable accuracy, convenience, and low cost (1) (2) (3) . Current guidelines recommend that physicians begin screening for the metabolic disturbances of CKD once the creatinine-based eGFR reaches 60 ml/min per 1.73 m 2 . Recent data, however, suggest that a strategy of using this single eGFR threshold, 60 ml/min per 1.73 m 2 , may disadvantage minority populations. Using the US Third National Health and Nutrition Examination Survey (NHANES III; 1988 through 1994) database, we found that a case definition of CKD with a single eGFR value of 60 ml/min per 1.73 m 2 seemed to disadvantage minority populations, because metabolic abnormalities such as high BP, anemia, and elevated phosphorus and uric acid were already considerably more prevalent at higher eGFR values in black than in white participants (4) . We believe that confirmation of these findings in a more recent, nationally representative population is of public health relevance, not least because of the changes in the demographic profile that have occurred since the conclusion of NHANES III (5). In addition, unlike more recent iterations of NHANES, parathyroid hormone (PTH) levels were not measured in NHANES III, preventing assessment of a classic metabolic complication of CKD. The objective of this study, therefore, was to determine whether a creatinine-based eGFR threshold of 60 ml/min per 1.73 m 2 , as calculated by the reexpressed Modification of Diet in Renal Disease (MDRD) Study formula and the African American Study of Kidney Disease and Hypertension (AASK) formula, identifies metabolic abnormalities equally well in minority and nonminority adult NHANES participants studied between 2003 and 2006 (n ϭ 8918). Metabolic abnormalities were defined by the fifth or 95th percentile of their respective distributions in the overall population. The specific threshold values were systolic BP Ն157.5 mmHg, diastolic BP Ն89.7 mmHg, potassium Ն4.5 mmol/L, hemoglobin Յ12.1 g/L, bicarbonate Յ20.5 mmol/L, uric acid Ն7.7 mg/dl, calcium Յ8.9 mg/dl, phosphorus Ն4.7 mg/dl, and PTH Ն81.5 pg/ml. PTH level was measured by the ECL/Origen electrochemiluminescent method, with a coefficient of variation Ͻ5% at all times (6). Self-reported diabetes was defined as an affirmative answer to the question, "Have you ever been told by a doctor that you have diabetes or sugar diabetes?" Self-reported hypertension was defined as an affirmative answer to the question, "Have you ever been told by a doctor or other health professional that you have hypertension, also called high BP?" 
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Of the study population, 72.9% were white, 11.0% were black, 11.4% were Hispanic, and 4.7% were of other races (Table  1) . Mean eGFR values were 82.9 ml/min per 1.73 m 2 for white individuals, 97.4 for black individuals, 100.6 for Hispanic individuals, and 92.5 for other races (P Ͻ 0.0001). Proportions with eGFR Ͻ60 ml/min per 1.73 m 2 were 9.5% of white individuals, 5.4% of black individuals, 2.8% of Hispanic individuals, and 5.0% of other races (P Ͻ 0.0001). Body mass index was significantly higher for black individuals. Unadjusting the MDRD GFR estimate for BSA gave the same trend in proportions with eGFR Ͻ60 ml/min per 1.73 m 2 , white Ͼ black Ͼ Hispanic individuals. Compared with estimates that adjusted for BSA, the largest decrement in the proportion with eGFR Ͻ60 was for white individuals. The proportions for urinary albumin-creatinine ratio Ͼ30 mg/g were 8.0% of white individuals, 12.1% of black individuals, 10.9% of Hispanic individuals, and 13.3% of other races (P Ͻ 0.0001). Table 2 compares mean levels of the clinical variables under scrutiny by race/ethnicity. For the overall population, differences between racial/ethnic groups were present for all variables except phosphorus; among individuals with eGFR Ͻ60 ml/min per .73 m 2 , differences were present for systolic BP, potassium, hemoglobin, uric acid, and PTH. Distribution of four CKD complications (abnormal potassium, hemoglobin, uric acid, and PTH levels) in white, Hispanic, and black individuals with eGFR Ͻ60 ml/min per 1.73 m 2 and in the overall population appear in Figure 1 . Because of the need to incorporate sampling weights into the statistical computation, these data cannot be presented as classic distribution curves. These graphs demonstrate a higher likelihood of these complications among black individuals. Table 3 shows odds ratio (OR) for metabolic abnormalities associated with different racial/ethnic categories in the overall cohort and for patients with eGFR Ͻ60 ml/min per 1.73 m 2 . With covariate adjustment, black participants were more likely than white participants to have abnormal systolic BP, diastolic BP, hemoglobin, uric acid, and PTH levels and less likely to have high potassium levels. The analysis that was restricted to participants with eGFR Ͻ60 ml/min per 1.73 m 2 showed that black participants were more likely to have abnormal hemoglobin, uric acid, and PTH levels.
Among black participants, correlation-regression analysis showed that GFR estimates were higher with the AASK equation than with the MDRD equation:
Whether the MDRD formula was used exclusively to adjust OR for metabolic abnormalities or the AASK formula was used for black participants, findings were similar with both strategies ( Figure 2 ). Using either strategy without adjustment for BSA also yielded similar results (data not shown).
Discussion
In this nationally representative US sample, black individuals were more likely than white individuals to have CKD-associated metabolic abnormalities, both in the overall population and among participants with eGFR Ͻ60 ml/min per 1.73 m 2 .
We found that black individuals had a lower prevalence of eGFR Ͻ60 ml/min per 1.73 m 2 , mirroring recent findings from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study (12) . The latter community-based study of adults aged Ն45 yr was designed to identify risk factors that contribute to excess mortality from stroke. Overall, the prevalence of eGFR Ͻ60 ml/min per 1. (15) (16) (17) (18) (19) (20) (21) (22) . These findings cannot be entirely explained by differences in calcium intake and vitamin D status, and the possibility that skeletal resistance to PTH may be partly responsible has been suggested (23) (24) (25) . Nevertheless, at least two lines of evidence suggest that hypovitaminosis D is common among black individuals and may be responsible for their higher PTH levels (26, 27) . Using NHANES III data, Martins et al. (27) demonstrated that 25-hydroxyvitamin D levels were lower in women and racial and ethnic minorities and in participants with diabetes, hypertension, and obesity. It is interesting that low levels of vitamin D were associated with hypertension, diabetes, and high triglyceride levels. The association between PTH and race was also reported by De Boer et al. (28) , who studied 218 individuals with mean GFR estimates of 34 ml/min per 1.73 m 2 and found that the mean adjusted PTH level was indeed higher in black individuals. Finally, it is tempting to speculate that the discrepancy between our study and older studies partly reflects sample size differences, referral population effects, and variability in the methods used to measure eGFR and PTH. Unlike many other variables, we found lower potassium levels in black individuals, when adjustment was made for eGFR and other covariates. In this regard, it has been suggested that black individuals may be relatively potassium deficient compared with white individuals. For example, urinary potassium excretion seems to be lower, whether on random diets or those with fixed potassium contents (29 -34) . Another recent study showed lower 24-h urinary potassium excretion rates for black than white women (35) . This finding has now been extended to men as well (36) . Among participants in the Dietary Approaches to Stop Hypertension (DASH) study, urinary potassium excretion was lower in black individuals, a phenomenon that persisted despite low potassium diet, suggesting that factors other than dietary intake are responsible. Given the reciprocal relationship between potassium deficiency and sodium retention, it has been suggested that variation in potassium handling may contribute to the higher than expected prevalence of hypertension among black individuals (37) . The observation that black individuals were more likely to have a lower hemoglobin level is consistent with previous studies (38 -41) . Most recently, this racial difference in anemia prevalence has been linked to excess mortality in elderly black individuals (42) .
Whether associations between serum creatinine and true GFR values differ in community-dwelling adults of different races and ethnicities and similar age and gender distribution (as they surely differ in black and Asian patients with CKD) cannot be determined from this analysis. Similarly, it is not possible to determine whether complications associated with declining eGFR develop at different eGFR levels or whether the higher prevalence of CKD-associated complications in minority groups with eGFR Ͻ60 ml/min per 1.73 m 2 reflects a greater prevalence of these complications in general. This may be the case for PTH but not for others, irrespective of eGFR level. The data presented here would tend to support the latter hypothesis. For example, in this study, compared with white participants, black participants had higher adjusted OR for low he- Figure 2 . In the top two panels, GFR was estimated using the Modification of Diet in Renal Disease (MDRD) Study formula for both white and black participants. In the bottom two panels, GFR was estimated using the MDRD Study formula for white participants and the African American Study of Kidney Disease and Hypertension (AASK) formula for black participants. White individuals are the reference category throughout. Race/ethnicity, age, gender, body mass index, born outside the United States, self-reported diabetes, self-reported hypertension, serum iron, and red blood cell folate were included as adjustment variables in all models; eGFR Ͻ60 ml/min per 1.73 m 2 was used in analysis of the overall population. Variable values: Systolic BP Ն157.7 mmHg, diastolic BP Ն89.7 mmHg, potassium Ն4.5 mmol/L, hemoglobin Յ12.1 g/dl, bicarbonate Յ20.5 mmol/L, uric acid Ն7.7 mg/d L, calcium Յ8.9 mg/dl, phosphorus Ն4.7 mg/dl, PTH Ն81.5 pg/ml. moglobin levels, regardless of whether eGFR levels were Ͻ60 ml/min per 1.73 m 2 , whether GFR was estimated using the MDRD Study formula or the AASK formula, or whether eGFR was unadjusted for BSA. This study is limited by its cross-sectional nature. Thus, it is not possible to determine whether black individuals develop metabolic abnormalities at higher eGFR levels than white individuals or to determine whether our findings can be explained by a higher population burden of these abnormalities. In addition, we did not use gold-standard methods to estimate GFR; this being said, the estimate is commonly used in clinical practice and forms the basis of most sets of clinical practice guidelines. Despite its limitations, we believe that the study has useful features that may help inform clinical practice and public health policy design. The sampling strategy facilitates quantification of the burden and the complications of CKD in a nationally representative US sample. Our use of a 6-yr cycle of NHANES participants, with significantly increased numbers of participants in subgroups, strengthens these findings.
Conclusions
Overall, the study suggests that detection strategies for metabolic abnormalities based on a single "one size fits all" threshold eGFR value may delay identifying these complications in black individuals.
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